Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials

References

• TreedeRDJensenTSCampbellJNNeuropathic pain: redefinition and a grading system for clinical and research purposesNeurology200870181630163518003941
   PubMed Web of Science ®Google Scholar
• SmithBHLeeJPriceCBaranowskiAPNeuropathic pain: a pathway for care developed by the British Pain SocietyBr J Anaesth20131111737923794648
   PubMed Web of Science ®Google Scholar
• BergerADukesEMOsterGClinical characteristics and economic costs of patients with painful neuropathic disordersJ Pain20045314314915106126
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol2010179e1113e1188
   PubMed Web of Science ®Google Scholar
• TorranceNFergusonJAAfolabiENeuropathic pain in the community: more under-treated than refractory?Pain2013154569069923485369
   PubMed Web of Science ®Google Scholar
• Pfizer IncLYRICA prescribing information Available from: http://www.pfizer.com/files/products/uspi_lyrica.pdfAccessed July 23, 2016
   Google Scholar
• Lyrica^® Summary of Product CharacteristicsSandwich, UKPfizer Ltd Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdfAccessed July 23, 2016
   Google Scholar
• O’ConnorABDworkinRHTreatment of neuropathic pain: an overview of recent guidelinesAm J Med200912210 SupplS22S32
   PubMed Web of Science ®Google Scholar
• BrilVEnglandJFranklinGMEvidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitationNeurology201176201758176521482920
   PubMed Web of Science ®Google Scholar
• DubinskyRMKabbaniHEl-ChamiZBoutwellCAliHQuality Standards Subcommittee of the American Academy of NeurologyPractice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200463695996515452284
   PubMed Web of Science ®Google Scholar
• MooreRAStraubeSWiffenPJDerrySMcQuayHJPregabalin for acute and chronic pain in adultsCochrane Database Syst Rev20093CD00707619588419
   PubMed Web of Science ®Google Scholar
• IMS MIDAS data from quarter ending June 2004 till quarter ending September 2016. Average daily dose based on IMS MIDAS data Q32016Data on file
   Google Scholar
• SnedecorSJSudharshanLCappelleriJCSadoskyAMehtaSBottemanMSystematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathyPain Pract201414216718423534696
   PubMed Web of Science ®Google Scholar
• JuhnMSParsonsBVarvaraRSadoskyAPregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy versus combination therapy, treatment-refractory patients, and adverse eventsCurr Med Res Opin20153151017102625772233
   PubMed Web of Science ®Google Scholar
• FreemanRDurso-DecruzEEmirBEfficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of dosesDiabetes Care20083171448145418356405
   PubMed Web of Science ®Google Scholar
• AsomaningKAbramskySLiuQZhouXSobelREWattSPregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care databaseInt J Clin Pract201670538038827028939
   PubMed Web of Science ®Google Scholar
• FreemanREmirBParsonsBPredictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trialsJ Pain Res2015825726826082659
   PubMed Web of Science ®Google Scholar
• StaceyBRBarrettJAWhalenEPhillipsKFRowbothamMCPregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain reliefJ Pain20089111006101718640074
   PubMed Web of Science ®Google Scholar
• FreynhagenRStrojekKGriesingTWhalenEBalkenohlMEfficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimensPain2005115325426315911152
   PubMed Web of Science ®Google Scholar
• GuanYDingXChengYEfficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in ChinaClin Ther201133215916621444113
   PubMed Web of Science ®Google Scholar
• van SeventerRBachFWTothCCPregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trialEur J Neurol20101781082108920236172
   PubMed Web of Science ®Google Scholar
• MoonDELeeDILeeSCEfficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter studyClin Ther201032142370238521353106
   PubMed Web of Science ®Google Scholar
• RichterRWPortenoyRSharmaULamoreauxLBockbraderHKnappLERelief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trialJ Pain20056425326015820913
   PubMed Web of Science ®Google Scholar
• LesserHSharmaULaMoreauxLPooleRMPregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trialNeurology200463112104211015596757
   PubMed Web of Science ®Google Scholar
• SharmaUGriesingTEmirBYoungJPJrTime to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgiaAm J Ther201017657758520393345
   PubMed Web of Science ®Google Scholar
• SabatowskiRGalvezRCherryDAPregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trialPain20041091–2263515082123
   PubMed Web of Science ®Google Scholar
• SiddallPJCousinsMJOtteAGriesingTChambersRMurphyTKPregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trialNeurology200667101792180017130411
   PubMed Web of Science ®Google Scholar
• DworkinRHCorbinAEYoungJPJrPregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialNeurology20036081274128312707429
   PubMed Web of Science ®Google Scholar
• RosenstockJTuchmanMLaMoreauxLSharmaUPregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trialPain2004110362863815288403
   PubMed Web of Science ®Google Scholar
• TolleTFreynhagenRVersavelMTrostmannUYoungJPJrPregabalin for relief of neuropathic pain associated with diabetic neu-ropathy: a randomized, double-blind studyEur J Pain200812220321317631400
   PubMed Web of Science ®Google Scholar
• van SeventerRFeisterHAYoungJPJrStokerMVersavelMRigaudyLEfficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trialCurr Med Res Opin200622237538416466610
   PubMed Web of Science ®Google Scholar
• ArezzoJCRosenstockJLamoreauxLPauerLEfficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trialBMC Neurol200883318796160
   PubMed Web of Science ®Google Scholar
• SimpsonDMSchifittoGCliffordDB1066 HIV Neuropathy Study GroupPregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trialNeurology201074541342020124207
   PubMed Web of Science ®Google Scholar
• CardenasDDNieshoffECSudaKA randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injuryNeurology201380653353923345639
   PubMed Web of Science ®Google Scholar
• OgawaSSuzukiMArakawaAArakiSYoshiyamaTEfficacy and tolerability of pregabalin for postherpetic neuralgia: a multicenter, randomized, double-blind, placebo-controlled clinical trialJ Japan Soc Pain Clin2010172141152
   Google Scholar
• SatohJYagihashiSBabaMEfficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trialDiabet Med201128110911621166852
   PubMed Web of Science ®Google Scholar
• SimpsonDMRiceASEmirBA randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathyPain2014155101943195424907403
   PubMed Web of Science ®Google Scholar
• RaskinPHuffmanCYurkewiczLPregabalin in Subjects With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover StudyClin J Pain201632320321025968451
   PubMed Web of Science ®Google Scholar
• HuffmanCStaceyBRTuchmanMEfficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on WalkingClin J Pain2015311194695825565583
   PubMed Web of Science ®Google Scholar
• LiuQChenHXiLA randomized, double-blind placebo-controlled trial to evaluate the efficacy and safety of pregabalin for postherpetic neuralgia in a population of Chinese patientsPain Pract2017171626926714731
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCFarrarJTCore outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain20051131–291915621359
   PubMed Web of Science ®Google Scholar
• FariesDEKadziolaZAAnalysis of longitudinal observational data using marginal structural modelsFariesDELeonACHaroJMAnalysis of Observational Health Care Data Using SASCary, NCSAS Institute Inc2010211230
   Google Scholar
• HernanMABrumbackBRobinsJMMarginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive menEpidemiology200011556157010955409
   PubMed Web of Science ®Google Scholar
• Pfizer LtdLyrica^® Summary of Product Characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdfAccessed July 23, 2016
   Google Scholar
• BaronRBinderAAttalNCasaleRDickensonAHTreedeRDNeuropathic low back pain in clinical practiceEur J Pain201620686187326935254
   PubMed Web of Science ®Google Scholar
• TaguchiTIgarashiAWattSEffectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in JapanJ Pain Res2015848749726346468
   PubMed Web of Science ®Google Scholar
• BaronRFreynhagenRTolleTRThe efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathyPain2010150342042720493632
   PubMed Web of Science ®Google Scholar
• FreynhagenRSerpellMEmirBA comprehensive drug safety evaluation of pregabalin in peripheral neuropathic painPain Pract2015151475724279736
   PubMed Web of Science ®Google Scholar
• LipkovichIAdamsDHMallinckrodtCFariesDBaronDHoustonJPEvaluating dose response from flexible dose clinical trialsBMC Psychiatry20088318179713
   PubMed Web of Science ®Google Scholar